Copyright © 2025 · HRTX | All rights reserved
- Long-Term Safety Surveillance
- Hybrid Registries
- Therapeutic & Comparative Effectiveness
- Short & Long-Term Outcomes
- Informed Consent Registries
- Managed Markets & Payer Initiatives
- Patient Reported Outcomes
- Real World Pragmatic Clinical Trials (PCTs)
- Provider Insights
Capabilities
HRTX-DOD studies cover any therapeutic area of interest. Rare diseases are often of particular interest.
We have successfully worked with most major biotechnology and pharmaceutical companies along with a number of specialty & rare disease organizations.
